So I spent way too much of my weekend digging through penny stocks that are trading under a dollar, and honestly there's some interesting stuff out there if you're willing to dig. Most of these companies are in biotech or pharma, which makes sense - they're risky but the upside could be massive if their research pans out.

I found a bunch of them trading under $1 that analysts were actually bullish on back in 2022. Like Ayala Pharmaceuticals was sitting at $0.63, working on rare cancer treatments. Then there's Aquestive Therapeutics with this dissolvable strip tech for medications - that one was at $0.91. Compugen was another one around $0.79, focused on cancer immunotherapy. Even Cybin, this psychedelic therapy company, was trading at $0.48. Gene therapy plays like Freeline and AVROBIO were also in that sub-dollar range.

What caught my attention is that most of these had analyst ratings saying 'buy' or 'strong buy' despite being so cheap. Like Sientra at $0.25 doing breast reconstruction tech, or Mogo helping Canadians manage finances at $0.80. Even Organigram, a cannabis producer, was sitting at $0.93.

Here's the thing though - this data is from late 2022, so obviously a lot has changed since then. These were stocks trading for less than a dollar back then, but I have no idea where they're at now. The whole point with penny stocks is they're super volatile. You could make bank or lose everything. That's why everyone says do your research and only throw money at this stuff you can afford to lose.

If you're actually considering picking up any stock less than $1, just remember the failure rate in biotech is brutal. Don't put your retirement money on this. But if you like the thrill and you've done your homework on the company's actual product and competition? Could be worth a shot.